Monday, February 13, 2023 10:49:07 PM
Did you notice this?
https://flashalert.me/?symbol=IMTX&source=SEC&referer=https://twitter.com/&url=https://www.sec.gov/Archives/edgar/data/1696029/000121390023010278/ea173206-13ga2dievini_immat.htm&s3=IMTX/2023-02-10/16-53-17_000000/SC%2013G/A/a7fde3b93846d15ce2863fe53eb01575/0001213900-23-010278-index.htm
Do you know anything about this organization?
https://www.dievini.de/
They are the ones reporting in the above sec filing to owning 17+ million shares of IMTX!
https://flashalert.me/?symbol=IMTX&source=SEC&referer=https://twitter.com/&url=https://www.sec.gov/Archives/edgar/data/1696029/000121390023010278/ea173206-13ga2dievini_immat.htm&s3=IMTX/2023-02-10/16-53-17_000000/SC%2013G/A/a7fde3b93846d15ce2863fe53eb01575/0001213900-23-010278-index.htm
Do you know anything about this organization?
https://www.dievini.de/
They are the ones reporting in the above sec filing to owning 17+ million shares of IMTX!
Recent IMTX News
- Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting • GlobeNewswire Inc. • 05/30/2026 12:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 09:03:55 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/12/2026 11:08:04 AM
- Immatics Announces First Quarter 2026 Financial Results and Business Update • GlobeNewswire Inc. • 05/12/2026 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/21/2026 02:40:20 PM
- Immatics Announces Four Upcoming Oral Presentations Across Its Clinical Cell Therapy and Bispecific Portfolio at 2026 ASCO Annual Meeting • GlobeNewswire Inc. • 04/21/2026 02:25:55 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/17/2026 07:06:45 PM
- PRAME-directed Cell Therapy Using Immatics’ TCR Induces Deep and Durable Remission in Pediatric Patient with Advanced Metastatic Nephroblastoma • GlobeNewswire Inc. • 04/17/2026 07:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 11:41:57 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 11:39:50 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 11:39:40 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 11:36:57 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 11:31:07 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 11:27:51 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 11:26:21 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 11:15:35 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 11:08:32 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 11:07:18 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 10:49:10 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 08:01:29 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/05/2026 12:12:59 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/05/2026 12:00:37 PM
- Immatics Announces Full Year 2025 Financial Results and Business Update • GlobeNewswire Inc. • 03/05/2026 12:00:00 PM
